Stimuli-responsive drug delivery systems based on polymeric nanovehicles are among the
most promising treatment regimens for malignant cancers. Such intelligent systems that …

To maximize the efficacy of anticancer drugs and minimize untoward side effects such as
nonspecific toxicity and the development of multi-drug resistance, nano-sized drug delivery …

The complexity of the tumor microenvironment presents significant challenges to cancer
therapy, while providing opportunities for targeted drug delivery. Using characteristic signals …

The conventional chemotherapeutic agents, used for cancer chemotherapy, have major
limitations including non-specificity, ubiquitous biodistribution, low concentration in tumor …

Conventional chemotherapy is the most common therapeutic method for treating cancer by
the application of small toxic molecules thatinteract with DNA and causecell death …

Nanoparticles and macromolecular carriers have been widely used to increase the efficacy
of chemotherapeutics, largely through passive accumulation provided by the enhanced …

Stimuli-responsive nanocarriers have the potential to revolutionize cancer treatment by
allowing precise delivery of drugs to the site of disease. The use of polymeric nanocarriers …

Background: Rapid developments in the field of nanoparticles during the last decades have
led to its increased application in drug delivery approaches. The advantages of nano-based …

Most of the conventional chemotherapeutic agents used against cancer have poor efficacy.
An approach to improve the efficacy of cancer chemotherapy is the development of carrier …

Nanotechnology-based antitumor drug delivery systems, known as nanocarriers, have
demonstrated their efficacy in recent years. Typically, the size of the nanocarriers is around …